Supplemental Table S3 shows the procedure codes, CMS fee schedule payments, and usage information used to develop cost inputs for screening visits, tests, and procedures</p
<p>Selection of studies on cost-effectiveness of HCV screening until November 2011.</p
Objective: To estimate costs and outcomes of conven-tional annual Papanicolaou (Pap) test screening ...
OBJECTIVE: To evaluate the long-term cost-effectiveness of different strategies for human papillomav...
Supplemental Table S1 shows the unpublished data from the IMPACT clinical trial referenced in for th...
Supplemental Table S2 shows the distribution of patient attributes in the prevalent US population of...
Supplemental Table S4 shows the top five most influential inputs based on the one-way sensitivity an...
Supplemental Figure S1 shows tornado diagrams of range of results observed in the one-way sensitivit...
Supplemental Figure S2 shows the proportion of the PSA simulations that were cost-effective at varyi...
Supplementary Table S3 shows CPT codes used in the analysis of colposcopy and related cervical servi...
Supplementary Table S1 includes codes used to identify cervical cancer screening tests within claims...
Objectives: The aim of this study was to evaluate the cost-effectiveness of cervical cancer screenin...
Supplementary Table S2 displays specifications for high and low-value cervical cancer screening as s...
<p>Selection of studies on cost-effectiveness of HCV screening; September 2011 until July 2015.</p
Objective To determine the most cost-effective screening programme for cervical cancer. Design Cost-...
Background: To assess the cost-effectiveness of alternative cervical cancer screening strategies to ...
<p>Selection of studies on cost-effectiveness of HCV screening until November 2011.</p
Objective: To estimate costs and outcomes of conven-tional annual Papanicolaou (Pap) test screening ...
OBJECTIVE: To evaluate the long-term cost-effectiveness of different strategies for human papillomav...
Supplemental Table S1 shows the unpublished data from the IMPACT clinical trial referenced in for th...
Supplemental Table S2 shows the distribution of patient attributes in the prevalent US population of...
Supplemental Table S4 shows the top five most influential inputs based on the one-way sensitivity an...
Supplemental Figure S1 shows tornado diagrams of range of results observed in the one-way sensitivit...
Supplemental Figure S2 shows the proportion of the PSA simulations that were cost-effective at varyi...
Supplementary Table S3 shows CPT codes used in the analysis of colposcopy and related cervical servi...
Supplementary Table S1 includes codes used to identify cervical cancer screening tests within claims...
Objectives: The aim of this study was to evaluate the cost-effectiveness of cervical cancer screenin...
Supplementary Table S2 displays specifications for high and low-value cervical cancer screening as s...
<p>Selection of studies on cost-effectiveness of HCV screening; September 2011 until July 2015.</p
Objective To determine the most cost-effective screening programme for cervical cancer. Design Cost-...
Background: To assess the cost-effectiveness of alternative cervical cancer screening strategies to ...
<p>Selection of studies on cost-effectiveness of HCV screening until November 2011.</p
Objective: To estimate costs and outcomes of conven-tional annual Papanicolaou (Pap) test screening ...
OBJECTIVE: To evaluate the long-term cost-effectiveness of different strategies for human papillomav...